Ambra BioScience LLC - Lovidia

About:

Ambra BioScience LLC - Lovidia is a proprietary gut sensory modulation technology platform.

Website: http://www.ambrabio.com

Twitter/X: ambrabio

Description:

Ambra BioScience LLC - Lovidia is a proprietary Gut Sensory Modulation Technology Platform used to create medical meals and dietary supplements that address important health and wellness issues, like preserving a healthy weight and blood sugar levels. They were concerned with the hormones that the L cells in the lower gut normally release. GLP-1, PYY, and oxyntomodulin are released when the nutrients in food naturally stimulate the bitter, umami, and sweet taste receptors found on the luminal side of the L-cells. These hormones have an impact on mood, glucose regulation, inflammation, and the regulation of hunger and fullness.

Total Funding Amount:

$2.22M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-11-16

Contact Email:

socialmedia(AT)ambrabio.com

Founders:

Martin Brown

Number of Employees:

11-50

Last Funding Date:

2017-12-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai